Adam L. Cohen

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla et al. · Nature Medicine · 2019 · 1.3K citations

Neuro-oncology, Neoadjuvant Anti-pd-1 Immunotherapy, Tumor Immunology +14

Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP

Liangliang Shen, John O'shea, Mohan R. Kaadige et al. · Proceedings of the National Academy of Sciences · 2015 · 216 citations · Full text

Combating subclonal evolution of resistant cancer phenotypes

Samuel W. Brady, Jasmine A. McQuerry, Stephen Piccolo et al. · Nature Communications · 2017 · 164 citations · Full text

A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma

Jiayi Huang, Rekha Chaudhary, Adam L. Cohen et al. · Journal of Neuro-Oncology · 2019 · 123 citations

Neuro-oncology, Oncology, Recurrent Temozolomide-resistant Glioblastoma +7

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

Priscilla K. Brastianos, Erin Twohy, Susan Geyer et al. · New England Journal of Medicine · 2023 · 117 citations · Full text